TipRanks
BriaCell Therapeutics Corp (BCTX)
NASDAQ:BCTX
US Market
BCTX
BriaCell Therapeutics
RESEARCH TOOLSreports

BriaCell Therapeutics (BCTX) Income Statement

335 Followers

BriaCell Therapeutics Income Statement

Last quarter (Q3 2026), BriaCell Therapeutics's total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q3, BriaCell Therapeutics's net income was C$-7.16M. See BriaCell Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jul 25Jul 24Jul 23Jul 22Jul 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -107.93K$ 0.00$ 0.00$ 0.00$ -15.55K
Operating Expenses
$ 27.43M$ 33.33M$ 23.27M$ 15.29M$ 6.97M
Depreciation and Amortization
$ 107.93K$ 83.90K$ 15.27K$ 15.27K$ 15.55K
EBITDA
$ -27.43M$ -4.85M$ -23.26M$ -26.82M$ -7.10M
Operating Income
$ -27.54M$ -33.33M$ -23.27M$ -15.29M$ -7.11M
Other Income/Expenses
$ 656.60K$ 28.40M$ 2.97M$ -11.55M$ -6.84M
Pretax Income
$ -26.88M$ -4.93M$ -20.30M$ -26.84M$ -13.82M
Net Income
$ -26.63M$ -4.79M$ -20.30M$ -26.84M$ -13.82M
Per Share Metrics
Basic EPS
$ -62.95$ -43.68$ -195.00$ -259.50$ -467.51
Diluted EPS
$ -62.95$ -43.68$ -195.00$ -259.50$ -467.51
Weighted Average Shares Outstanding
 423.11K 109.70K 104.13K 103.29K 30.13K
Weighted Average Shares Outstanding (Diluted)
 423.11K 109.70K 104.13K 103.29K 30.13K

BriaCell Therapeutics Earnings and Revenue History